Murine BAFF-receptor residues 168-175 are essential for optimal CD21/35 expression but dispensable for B cell survival

Molecular Immunology

Volumn 47, Issue 2-3, 2009, Pages 590-599

  Mayne, Christopher G ^a   Amanna, Ian J ^b   Hayes, Colleen E ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

B cell development; BAFF R; CD21 35; Survival signaling

Indexed keywords

B CELL ACTIVATING FACTOR RECEPTOR; COMPLEMENT COMPONENT C3B RECEPTOR; COMPLEMENT COMPONENT C3D RECEPTOR; DOUBLE STRANDED DNA; RETROVIRUS VECTOR; THREONINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CARBOXY TERMINAL SEQUENCE; CELL MATURATION; CELL SURVIVAL; CONTROLLED STUDY; CYTOPLASM; DELETION MUTANT; FEMALE; GENE INSERTION; GENE MUTATION; HOMOZYGOTE; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN FUNCTION; RETROPOSON; SIGNAL TRANSDUCTION; WILD TYPE;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; AMINO ACIDS; ANIMALS; B-CELL ACTIVATION FACTOR RECEPTOR; B-LYMPHOCYTES; CELL SURVIVAL; DNA MUTATIONAL ANALYSIS; FEMALE; GENE EXPRESSION REGULATION; GENETIC VECTORS; MALE; MICE; MOLECULAR SEQUENCE DATA; MUTANT PROTEINS; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, COMPLEMENT 3B; RECEPTORS, COMPLEMENT 3D; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP;

MURINAE; MUS;

EID: 70450224871     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2009.09.010     Document Type: Article

References (36)

1. Allman D., Lindsley R.C., DeMuth W., Rudd K., Shinton S.A., and Hardy R.R. Resolution of three nonproliferative immature splenic B cell subsets reveals multiple selection points during peripheral B cell maturation. J. Immunol. 167 (2001) 6834-6840
2. Amanna I.J., Clise-Dwyer K., Nashold F.E., Hoag K.A., and Hayes C.E. Cutting edge: A/WySnJ transitional B cells overexpress the chromosome 15 proapoptotic Blk gene and succumb to premature apoptosis. J. Immunol. 167 (2001) 6069-6072
3. Amanna I.J., Dingwall J.P., and Hayes C.E. Enforced bcl-x(L) gene expression restored Splenic B lymphocyte development in BAFF-R mutant mice. J. Immunol. 170 (2003) 4593-4600
4. Batten M., Groom J., Cachero T.G., Qian F., Schneider P., Tschopp J., Browning J.L., and Mackay F. BAFF mediates survival of peripheral immature B lymphocytes. J. Exp. Med. 192 (2000) 1453-1466
5. Cariappa A., Tang M., Parng C., Nebelitskiy E., Carroll M., Georgopoulos K., and Pillai S. The follicular versus marginal zone B lymphocyte cell fate decision is regulated by Aiolos, Btk, and CD21. Immunity 14 (2001) 603-615
6. Claudio E., Brown K., Park S., Wang H., and Siebenlist U. BAFF-induced NEMO-independent processing of NF-kappa B2 in maturing B cells. Nat. Immunol. 3 (2002) 958-965
7. Debnath I., Roundy K.M., Weis J.J., and Weis J.H. Analysis of the regulatory role of BAFF in controlling the expression of CD21 and CD23. Mol. Immunol. 44 (2007) 2388-2399
8. Fearon D.T., and Carroll M.C. Regulation of B lymphocyte responses to foreign and self-antigens by the CD19/CD21 complex. Annu. Rev. Immunol. 18 (2000) 393-422
9. Gardam S., Sierro F., Basten A., Mackay F., and Brink R. TRAF2 and TRAF3 signal adapters act cooperatively to control the maturation and survival signals delivered to B cells by the BAFF receptor. Immunity 28 (2008) 391-401
10. Gorelik L., Cutler A.H., Thill G., Miklasz S.D., Shea D.E., Ambrose C., Bixler S.A., Su L., Scott M.L., and Kalled S.L. Cutting edge: BAFF regulates CD21/35 and CD23 expression independent of its B cell survival function. J. Immunol. 172 (2004) 762-766
11. Guo B., Su T.T., and Rawlings D.J. Protein kinase C family functions in B-cell activation. Curr. Opin. Immunol. 16 (2004) 367-373
12. Kayagaki N., Yan M., Seshasayee D., Wang H., Lee W., French D.M., Grewal I.S., Cochran A.G., Gordon N.C., Yin J., Starovasnik M.A., and Dixit V.M. BAFF/BLyS receptor 3 binds the B cell survival factor BAFF ligand through a discrete surface loop and promotes processing of NF-kappaB2. Immunity 17 (2002) 515-524
13. Liao G., Zhang M., Harhaj E.W., and Sun S.C. Regulation of the NF-kappaB-inducing kinase by tumor necrosis factor receptor-associated factor 3-induced degradation. J. Biol. Chem. 279 (2004) 26243-26250
14. Mackay F., Sierro F., Grey S.T., and Gordon T.P. The BAFF/APRIL system: an important player in systemic rheumatic diseases. Curr. Dir. Autoimmun. 8 (2005) 243-265
15. Mackay F., Silveira P.A., and Brink R. B cells and the BAFF/APRIL axis: fast-forward on autoimmunity and signaling. Curr. Opin. Immunol. 19 (2007) 327-336
16. Martin B.K. Transcriptional control of complement receptor gene expression. Immunol. Res. 39 (2007) 146-159
17. Mayne C.G., Amanna I.J., Nashold F.E., and Hayes C.E. Systemic autoimmunity in BAFF-R-mutant A/WySnJ strain mice. Eur. J. Immunol. 38 (2008) 587-598
18. Mayne C.G., Nashold F.E., Sasaki Y., and Hayes C.E. Altered BAFF-receptor signaling and additional modifier loci contribute to systemic autoimmunity in A/WySnJ mice. Eur. J. Immunol. 39 (2009) 589-599
19. Miller D.J., and Hayes C.E. Phenotypic and genetic characterization of a unique B lymphocyte deficiency in strain A/WySnJ mice. Eur. J. Immunol. 21 (1991) 1123-1130
20. Miller D.J., Hanson K.D., Carman J.A., and Hayes C.E. A single autosomal gene defect severely limits IgG but not IgM responses in B lymphocyte-deficient A/WySnJ mice. Eur. J. Immunol. 22 (1992) 373-379
21. Ni C.Z., Oganesyan G., Welsh K., Zhu X., Reed J.C., Satterthwait A.C., Cheng G., and Ely K.R. Key molecular contacts promote recognition of the BAFF receptor by TNF receptor-associated factor 3: implications for intracellular signaling regulation. J. Immunol. 173 (2004) 7394-7400
22. Oliver A.M., Martin F., and Kearney J.F. IgMhighCD21high lymphocytes enriched in the splenic marginal zone generate effector cells more rapidly than the bulk of follicular B cells. J. Immunol. 162 (1999) 7198-7207
23. Pear W.S., Miller J.P., Xu L., Pui J.C., Soffer B., Quackenbush R.C., Pendergast A.M., Bronson R., Aster J.C., Scott M.L., and Baltimore D. Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving P210 bcr/abl-transduced bone marrow. Blood 92 (1998) 3780-3792
24. Rahman Z.S., and Manser T. B cells expressing Bcl-2 and a signaling-impaired BAFF-specific receptor fail to mature and are deficient in the formation of lymphoid follicles and germinal centers. J. Immunol. 173 (2004) 6179-6188
25. Rahman Z.S., Rao S.P., Kalled S.L., and Manser T. Normal induction but attenuated progression of germinal center responses in BAFF and BAFF-R signaling-deficient mice. J. Exp. Med. 198 (2003) 1157-1169
26. Sasaki Y., Casola S., Kutok J.L., Rajewsky K., and Schmidt-Supprian M. TNF family member B cell-activating factor (BAFF) receptor-dependent and -independent roles for BAFF in B cell physiology. J. Immunol. 173 (2004) 2245-2252
27. Sasaki Y., Calado D.P., Derudder E., Zhang B., Shimizu Y., Mackay F., Nishikawa S., Rajewsky K., and Schmidt-Supprian M. NIK overexpression amplifies, whereas ablation of its TRAF3-binding domain replaces BAFF: BAFF-R-mediated survival signals in B cells. Proc. Natl. Acad. Sci. U.S.A. 105 (2008) 10883-10888
28. Schiemann B., Gommerman J.L., Vora K., Cachero T.G., Shulga-Morskaya S., Dobles M., Frew E., and Scott M.L. An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway. Science 293 (2001) 2111-2114
29. Shulga-Morskaya S., Dobles M., Walsh M.E., Ng L.G., MacKay F., Rao S.P., Kalled S.L., and Scott M.L. B cell-activating factor belonging to the TNF family acts through separate receptors to support B cell survival and T cell-independent antibody formation. J. Immunol. 173 (2004) 2331-2341
30. Siebenlist U., Brown K., and Claudio E. Control of lymphocyte development by nuclear factor-kappaB. Nat. Rev. Immunol. 5 (2005) 435-445
31. Strasser A., Whittingham S., Vaux D.L., Bath M.L., Adams J.M., Cory S., and Harris A.W. Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 8661-8665
32. Tardivel A., Tinel A., Lens S., Steiner Q.G., Sauberli E., Wilson A., Mackay F., Rolink A.G., Beermann F., Tschopp J., and Schneider P. The anti-apoptotic factor Bcl-2 can functionally substitute for the B cell survival but not for the marginal zone B cell differentiation activity of BAFF. Eur. J. Immunol. 34 (2004) 509-518
33. Thompson J.S., Bixler S.A., Qian F., Vora K., Scott M.L., Cachero T.G., Hession C., Schneider P., Sizing I.D., Mullen C., Strauch K., Zafari M., Benjamin C.D., Tschopp J., Browning J.L., and Ambrose C. Baff-R, a newly identified TNF receptor that specifically interacts with baff. Science 293 (2001) 2108-2111
34. von Bulow G.U., van Deursen J.M., and Bram R.J. Regulation of the T-independent humoral response by TACI. Immunity 14 (2001) 573-582
35. Xu L.G., and Shu H.B. TNFR-associated factor-3 is associated with BAFF-R and negatively regulates BAFF-R-mediated NF-kappa B activation and IL-10 production. J. Immunol. 169 (2002) 6883-6889
36. Yan M., Brady J.R., Chan B., Lee W.P., Hsu B., Harless S., Cancro M., Grewal I.S., and Dixit V.M. Identification of a novel receptor for B lymphocyte stimulator that is mutated in a mouse strain with severe B cell deficiency. Curr. Biol. 11 (2001) 1547-1552